• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

10,017
2,295
1,798
1,794
1,739

COUNTRY

807
621
258
244
227

CATEGORIES

  • 718
  • 150
  • 951
  • 1,082
    • 108
  • 357
  • 252
  • 200
  • 64
  • 372
  • 634
  • 1,035
  • 1,615
  • 625
  • 871
  • 1,574
  • 2,482
    • 576
    • 122
    • 558
    • 80
    • 530
    • 43
    • 507
    • 17
    • 19
    • 25
  • 505
  • 704
  • 0
  • 135

PRICE

5,755
10,330
15,090
22,923

PUBLISHED

1,675
2,418
6,692
22,923

PRODUCT TYPE

18,536
3,187
862
142
73
46
21
21
21
8
6

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic...

April 2014
FROM

Mycosis Fungoides Global Clinical Trials Review, H1, 2014

Mycosis Fungoides Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H1, 2014" provides data on the Mycosis Fungoides clinical...

April 2014
FROM

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the...

April 2014
FROM

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014" provides data...

April 2014
FROM

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Metastatic Hormone Refractory...

April 2014
FROM

Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014

Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014"...

April 2014
FROM

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014" provides data on the Refractory...

April 2014
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory...

April 2014
FROM

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent...

April 2014
FROM

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials...

April 2014
FROM

Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014

Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014" provides data...

April 2014
FROM

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014"...

April 2014
FROM

Advances in Immunology, Vol 122

Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that...

April 2014

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’ provides in-depth analysis...

April 2014
FROM

HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth

'HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth' provides insights into the...

April 2014
FROM
Biofilms in Infection Prevention and Control Biofilms in Infection Prevention and Control - Product Thumbnail Image

Biofilms in Infection Prevention and Control

Biofilms in Infection and Disease Control: A Healthcare Handbook outlines the scientific evidence and rationale for the prevention of infection, the role biofilms play in infection control, and the...

April 2014
Biomarkers in Toxicology Biomarkers in Toxicology - Product Thumbnail Image

Biomarkers in Toxicology

Biomarkers in Toxicology is a timely and comprehensive reference dedicated to all aspects of biomarkers that relate to chemical exposure and their effects on biological systems. This book includes both...

April 2014
Cough, Cold and Allergy (Hay Fever) Remedies in Greece Cough, Cold and Allergy (Hay Fever) Remedies in Greece - Product Thumbnail Image

Cough, Cold and Allergy (Hay Fever) Remedies in Greece

Seasonality remains the key factor determining the performance of cough, cold and allergy (hay fever) remedies in Greece. The category remains highly dependent on the prevailing weather conditions and...

April 2014
FROM

Hepatitis Global Market Report - 2014

The authors, who are leaders in pharmaceutical and life-science consulting, have conducted an extensive global physician survey and analysis in hepatitis to provide a comprehensive market report Information...

April 2014
Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan - Product Thumbnail Image

Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan

Cough, cold and allergy (hay fever) remedies registered a 22%increase in current value sales in 2013 to reachPKR2.4 billion. Issues with ephedrine continued in 2013. The Cough, Cold and Allergy (Hay...

April 2014
FROM
Loading Indicator

Our Clients

Our clients' logos